The blood pressure medication recall 2026 situation has drawn renewed attention after a nationwide recall involving certain chlorthalidone 25 mg tablets manufactured by Inventia Healthcare Limited. The recall concerns a specific batch that did not meet required dissolution specifications, raising concerns about whether the tablets may release their active ingredient properly. The U.S. Food and Drug Administration has classified the recall as Class II, while patients are being advised to verify their prescription information and speak with a pharmacist or healthcare professional before making changes to treatment.
Key Points Summary
╔════════════════════════════════════════════════════════════════════╗
║ – Certain chlorthalidone 25 mg tablets manufactured by Inventia Healthcare Limited are involved in the latest recall. ║
║ – The September recall affects 13,567 bottles from lot RISA24002. ║
║ – The affected product is packaged as 100 tablets per bottle and carries NDC 64980-599-01. ║
║ – The recalled lot has an expiration date of April 2027 and was recalled after failing dissolution specifications. ║
║ – The FDA classified the recall as Class II, indicating potential temporary or medically reversible health consequences. ║
║ – Patients should check the lot number on their medication bottle and contact a pharmacist before stopping or replacing their prescription. ║
╚════════════════════════════════════════════════════════════════════╝
What Is the Latest Chlorthalidone Recall?
The latest recall involves a particular lot of chlorthalidone 25 mg tablets. Chlorthalidone is a prescription diuretic, commonly known as a water pill, that is used to help control high blood pressure.
The medication works by helping the kidneys remove excess sodium and water from the body. Reducing excess fluid can help lower blood pressure and may also be useful for certain patients who experience fluid retention.
The recall does not apply to every chlorthalidone tablet on the market. Instead, it is limited to a specific product, manufacturer, lot and packaging configuration.
The affected September 2026 product is identified as:
- Medication: Chlorthalidone Tablets, USP
- Strength: 25 mg
- Manufacturer: Inventia Healthcare Limited
- NDC: 64980-599-01
- Package size: 100 tablets
- Lot number: RISA24002
- Expiration date: April 2027
- Quantity affected: 13,567 bottles
Patients should use the lot number as an important part of their check because other chlorthalidone products may not be included in the recall.
Why Were the Tablets Recalled?
The central issue is a failed dissolution specification.
Dissolution testing is an important part of pharmaceutical quality control. It evaluates how a tablet releases its active ingredient after it is taken. A medication must dissolve appropriately so that the active ingredient can become available for absorption by the body.
When a tablet fails its required dissolution specification, there can be uncertainty about whether the drug will be released in the expected manner.
For chlorthalidone, that matters because the medicine is prescribed to help manage blood pressure and, in some cases, fluid retention. If a recalled tablet does not perform as expected, its effectiveness could potentially be affected.
The recall therefore focuses on the quality of the affected lot rather than suggesting that chlorthalidone itself is unsafe as a medication.
What Does an FDA Class II Recall Mean?
The FDA uses different classifications to communicate the potential health risk associated with recalled products.
A Class II recall generally means that use of or exposure to the recalled product could result in temporary or medically reversible health consequences, while the likelihood of serious adverse health effects is considered remote.
That classification does not mean every person who took a recalled tablet will become sick.
It also does not mean patients should immediately discontinue their prescription without professional advice.
The appropriate response depends on the exact medication, the patient’s medical circumstances and whether an alternative supply is available.
How Patients Can Check Their Prescription Bottle
The easiest way to determine whether a prescription may be affected is to inspect the bottle or original packaging.
Patients should look for several pieces of information rather than relying only on the drug’s name.
For the latest recalled lot, the important details are:
Chlorthalidone 25 mg
NDC: 64980-599-01
Lot: RISA24002
Expiration: 04/2027
Manufacturer: Inventia Healthcare Limited
If the information on the bottle matches these details, patients should contact their pharmacy or healthcare provider for instructions.
People who cannot locate the lot number should not guess. A pharmacist can review the prescription packaging and determine whether the product is part of the affected recall.
Should Patients Stop Taking Chlorthalidone?
Patients should not independently stop a prescription blood pressure medication simply because they see a recall report online.
Chlorthalidone is taken regularly by many people to help maintain blood pressure control. Suddenly skipping doses can allow blood pressure to rise and may create problems depending on the patient’s medical history and other medications.
Instead, anyone who believes they have a recalled lot should contact the pharmacy that dispensed the prescription.
The pharmacist can determine whether the specific product is affected and explain what replacement options are available.
A prescribing clinician may also be able to recommend an alternative medication or treatment plan if necessary.
The goal is to avoid unnecessary interruption while making sure patients do not continue using a product that has been specifically identified as part of the recall.
What If You Have Already Taken the Recalled Tablets?
Taking medication from a recalled lot does not automatically mean that a patient will experience an adverse reaction.
The reason for this particular recall is a manufacturing quality concern involving dissolution testing. The recall is designed to remove potentially affected product from distribution and prevent continued use of tablets that may not meet established specifications.
Patients who have already taken tablets from the affected lot should not panic.
Instead, they should identify the bottle, confirm the lot number and speak with a pharmacist or healthcare professional. The medical professional can determine whether additional monitoring or a replacement prescription is necessary.
Patients should also tell their healthcare provider about any unusual symptoms or changes they notice.
Why Blood Pressure Control Matters
High blood pressure often does not produce noticeable symptoms, which is one reason consistent treatment is important.
For many patients, blood pressure medication is part of a long-term treatment plan that may also include diet, exercise, weight management, reduced sodium intake and other lifestyle measures.
When a prescription is recalled, the concern is not simply the bottle itself. Patients also need to make sure their underlying condition remains controlled.
That is why pharmacists and doctors generally recommend identifying an appropriate replacement rather than simply abandoning treatment.
Anyone with questions about an individual blood pressure reading or medication change should discuss those concerns with a qualified healthcare professional.
Does the Recall Affect Every Chlorthalidone Product?
No.
A recall involving a particular lot does not automatically mean that every product containing the same active ingredient has been recalled.
Chlorthalidone can be produced by different manufacturers and distributed in different package sizes and strengths. Products can also have different NDC numbers and lot numbers.
This makes it important to distinguish between a drug-level recall and a specific-lot recall.
In this case, the latest action concerns particular Inventia Healthcare tablets. Patients should therefore compare their own prescription information with the recall details instead of assuming that all chlorthalidone products are affected.
Earlier Chlorthalidone Recall Activity in 2026
The latest action follows another chlorthalidone recall involving Inventia Healthcare earlier in 2026.
Earlier recalled lots included RISA24001 and RISB24002, which were also associated with dissolution testing concerns.
The existence of multiple affected lots makes it especially important for patients to check the complete product information on their bottles.
Two bottles containing the same medication name can have different lot numbers and therefore have different recall statuses.
Patients should not rely on an old recall article, social media post or generalized headline when determining whether their own medication is affected.
The lot number and NDC provide much more precise information.
What Is an NDC Number?
The National Drug Code, commonly called the NDC, is an identifier used for medications marketed in the United States.
It helps distinguish products based on the manufacturer or labeler, the specific drug and its package configuration.
For the latest affected chlorthalidone product, the NDC is 64980-599-01.
Patients may see the NDC printed on the pharmacy label or medication packaging. Depending on the pharmacy system, the format may appear slightly different from the way it is presented in a recall notice.
If a patient is unsure whether the NDC corresponds to the recalled product, the pharmacist can verify it.
What Should You Ask Your Pharmacist?
If your bottle appears to match the recalled product, several questions can help clarify the next step.
Patients can ask:
- Is my specific lot included in the recall?
- Should I continue taking the medication until a replacement is available?
- Can you provide an unaffected supply?
- Do I need a new prescription?
- Should my blood pressure be monitored more frequently?
- What should I do with the recalled tablets?
- Are there any symptoms I should watch for?
A pharmacist can often resolve these questions quickly because the pharmacy has access to dispensing records and product information.
Patients using mail-order prescriptions should also contact their mail-order pharmacy if the bottle appears to match the recalled lot.
What Symptoms Require Urgent Medical Attention?
Medication recalls should not be confused with emergency medical diagnoses.
However, people taking blood pressure medication should know the warning signs that require prompt medical attention.
Symptoms such as severe chest pain, significant difficulty breathing, sudden weakness or numbness, trouble speaking, severe confusion, major vision changes or other serious neurological symptoms can require emergency evaluation.
Patients who experience severe or rapidly worsening symptoms should seek emergency medical care rather than waiting for a pharmacy or recall-related response.
A medication recall should never delay emergency treatment.
How Medication Recalls Protect Patients
Drug recalls are an important part of the pharmaceutical safety system.
Manufacturers, pharmacies and regulators can identify quality problems through manufacturing investigations, testing, complaints and other monitoring processes.
When a problem is identified, a recall can help remove potentially affected products from distribution.
Not every recall indicates that a medication is broadly dangerous. Some recalls involve manufacturing defects, packaging mistakes, labeling issues or problems limited to specific lots.
The classification and reason for each recall provide important context.
For consumers, the most useful information is often the exact product identification, including the manufacturer, strength, NDC, lot number and expiration date.
What Patients Should Watch For Next
The recall status of medications can change as companies and regulators review affected products.
Patients should watch for updated information from their pharmacy and healthcare provider, particularly if they use a medication every day.
People who take multiple medications may also want to keep a current medication list containing the name, strength and prescribing instructions for each drug.
That information can make it easier to identify a recalled product and obtain an appropriate replacement.
It can also reduce confusion when different manufacturers supply the same generic medicine.
Why Online Recall Headlines Can Be Misleading
Searches for medication recalls can produce headlines that make a specific recall appear broader than it really is.
A report describing a recalled lot of chlorthalidone does not necessarily mean all chlorthalidone has been recalled.
Similarly, a recall involving one manufacturer’s product does not automatically extend to products made by other manufacturers.
Consumers should therefore examine the details behind a recall rather than relying solely on a headline.
This is particularly important for people taking medications for chronic conditions, where an unnecessary interruption can create additional concerns.
What the Current Blood Pressure Medication Recall 2026 Means for Patients
The blood pressure medication recall 2026 involving Inventia Healthcare is focused on specific chlorthalidone 25 mg tablets that failed dissolution specifications.
The most recent affected lot is RISA24002, involving 13,567 bottles of 100 tablets. The product carries NDC 64980-599-01 and has an April 2027 expiration date.
The FDA’s Class II classification indicates that the potential health consequences associated with the recalled product are considered temporary or medically reversible, with serious consequences considered unlikely.
Patients who take chlorthalidone should check their medication bottle carefully rather than assuming they are affected.
If the lot information matches the recalled product, the next step should be a conversation with a pharmacist or healthcare professional. Patients should not independently stop or change their blood pressure treatment without appropriate medical guidance.
Final Takeaway
The latest recall is limited to specific chlorthalidone tablets and does not mean that every blood pressure medication or every chlorthalidone prescription is affected.
The most important step for patients is to check the medication label, identify the manufacturer and lot number, and compare those details with the affected product information. Anyone who believes they have a recalled bottle should contact a pharmacist or healthcare provider to determine the safest replacement or treatment plan.
For people managing hypertension, maintaining continuity of appropriate care remains important. A recall should prompt verification and professional guidance, not an abrupt decision to stop medication.
Stay alert to medication recall updates, check your prescription labels carefully, and speak with your pharmacist whenever you have questions about a recalled blood pressure medicine.